New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Open Access
- 1 July 2008
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 5 (3) , 409-414
- https://doi.org/10.1016/j.nurt.2008.05.011
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Clearance of amyloid-β by circulating lipoprotein receptorsNature Medicine, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2007
- Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotypeProceedings of the National Academy of Sciences, 2007
- Cognitive impact of subcortical vascular and Alzheimer's disease pathologyAnnals of Neurology, 2006
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Clearance of Alzheimer's Aβ PeptideNeuron, 2004
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Amyloidosis and Alzheimer’s diseaseAdvanced Drug Delivery Reviews, 2002
- Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into bloodNeurobiology of Aging, 2002
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996